Introduction
============

Epidemiological studies show that diets high in fruits and vegetables are associated with lower risk of cardiovascular disease, stroke, and cancer, and with increased longevity ([@b10-cia-2-147]; [@b9-cia-2-147]; [@b18-cia-2-147]; [@b3-cia-2-147]). Whether these protective effects are directly attributable to vitamins C or E or other food constituents is not known.

Cerebral ischemia results in vascular (endothelial) damage, and tissue injury (infarction). Tissue injury in the acute phase generates increase production of oxygen (O~2~^−^) radical, which in turn triggers necrosis in the acute phase, inflammatory responses in the subacute phase, and apoptosis in the chronic phase. This oxidative stress increases the permeability of the blood-brain barrier leading to edema, and tends to increase lesion volume and neurological impairment in stroke ([@b11-cia-2-147]).

[@b2-cia-2-147], [@b4-cia-2-147], and [@b14-cia-2-147], in their respective studies have shown that the serum levels of most of the antioxidants (including vitamin C levels) are reduced immediately after an acute ischemic stroke compared with controls, presumably as a consequence of increased oxidative stress. Inflammatory markers (C-reactive protein, intercellular adhesion molecule-1, monocyte chemotactic protein-1) are increased simultaneously. Intervention studies with vitamin C have shown no change in markers of oxidation or clinical benefit in chronic diseases particularly diabetes mellitus ([@b12-cia-2-147]). [@b15-cia-2-147], studied the markers of vascular function in 31 young healthy male adults, who were administered a daily dosage of 1000 mg vitamin C, 800 mg vitamin E, and 10 mg folate. Beneficial decreases in diastolic blood pressure due to increase in arterial compliance after 12 weeks of vitamin supplementation was noted, while no statistically significant changes were observed with other cardiovascular variables such as systolic blood pressure, stroke volume, heart rate, cardiac output, vascular resistance, and arterial compliance.

In contrast to the epidemiological data on diet and stroke incidence and severity, and clinical intervention studies in the acute phase, no prior studies have addressed the effectiveness of vitamin C supplementation on functional recovery in patients undergoing rehabilitation after an ischemic stroke.

Method
======

Patients
--------

Of the stroke patients admitted to our designated acute stroke rehabilitation unit over a 12-month period, 23 recovering ischemic stroke patients on vitamin C were matched to 23 recovering ischemic stroke patients not on vitamin C (control). The inclusion criteria were: first ischemic stroke event, and neuroimaging (computed tomography and/or magnetic resonance imaging) showing ischemic lesion corresponding to the clinical signs and symptoms. The exclusion criteria were: hemorrhagic stroke and recurrent ischemic stroke. Patients were matched for age; sex, onset-to-admission, and admission total functional independence measure (TFIM), which are factors known to influence functional motor recovery. The physician and the rehabilitation team members prospectively recorded the data in a computerized stroke database.

Intervention(s)
---------------

Ischemic stroke patients who were undernourished (defined as significant weight loss, and/or 90% or less ideal body weight for age and sex, and an admission serum albumin \<3.4 gm/dl) and/or had the presence of pressure sores were administered 1000 mg of vitamin C daily as part of its treatment protocol. Our institution's Institutional Review Board approval was not obtained because administration of vitamin C for undernourished patients and/or presence of pressure sore are considered a part of the standard of care at our institution.

Quantifiable outcome measures
-----------------------------

The primary outcome measures were: change in the TFIM score, FIM-Cognition (FIM-Cog), and FIM-Motor sub-scores. The secondary outcome measures were: discharge disposition (home discharge vs. long-term care facility) and length of stay (LOS).

The Functional Independence Measure (FIM™) tool was used to measure the degree of disability as well as the progress the patients made through medical rehabilitation programs ([@b5-cia-2-147]). The FIM scale is a reliable ([@b17-cia-2-147]) and a valid functional independence measure ([@b16-cia-2-147]). The FIM has become the standard functional assessment measures of self-care and mobility in rehabilitation medicine in the United States. The FIM is an 18-item ordinal scale scored from 1 to 7. A FIM item score of seven is categorized as "complete independence", while a score of one is "total assist". The possible total score ranges from 18 (maximum level of dependence) to 126 (highest level of independence). Stroke rehabilitation team members who are FIM-certified scored the admission and discharge total FIM score.

Data analysis
-------------

Groups were compared for demographic data and outcome measures. Continuous and nominal variables between the two groups were analyzed using Student's t-test and Chi-square analyses.

A p \< 0.05 significance level was used for all analyses. The statistical analysis was carried out by commercial statistical software package Stat View (version 5.0.1 SAS Institute Inc. Cary, NC 27513; 1992 to 1998). Subgroup analysis was done by paired t-test in Excel.

Results
-------

[Table 1](#t1-cia-2-147){ref-type="table"} presents the demographics of our study sample (n = 46) for the 2 groups based on presence or absence of vitamin C supplementation intake. The mean age (±SD) of our patients was 76 ± 11 years (range 49--89 years). The male/female ratio was 26/20. The onset of stroke to admission to our unit was 11 ± 6 days. The admission TFIM score was 41 ± 18. The average LOS in our study population was 19 ± 11 days. The vitamin C treated (n = 23) versus control (n = 23) group were well matched for: age (p = 0.84), M/F ratio (p = 1.0), onset-to-admission (p = 0.38), prior level of physical independence (p = 1.0), and admission TFIM (p = 0.99) ([Table 1](#t1-cia-2-147){ref-type="table"}). There were 15 patients in the vitamin C group and only 1 patient in the control group (p = 0.0001) who had pressure sores.

The changes in TFIM (p = 0.20), FIM-Cog (p = 0.41), and FIM-Motor (p = 0.21) sub-scores were consistently less in the Vitamin C treated group compared with the controls but the differences did not reach statistical significance ([Table 2](#t2-cia-2-147){ref-type="table"}). Similarly, no significant differences were found between the 2 groups for LOS (p = 0.59), and discharge disposition to home/or institution (p = 0.60). In view of the lack of difference between the primary and secondary outcome measures between the 2 groups, a post-hoc analysis between the two groups for the primary outcome variables in the undernourished ischemic stroke patients (n = 8) versus their cognate controls (n = 8) was undertaken. The p value (0.07, but power \<0.8) failed to reach pre-set levels for statistical significance (p \< 0.05), but possibly suggested that individual displaying evidence of malnourishment had worse outcomes.

Discussion
==========

In this retrospective, case-study, administration of vitamin C supplementation did not improve functional recovery in ischemic stroke patients. However, ischemic stroke patients who had pressure sores and were assigned to the vitamin C group had a much lesser change in the functional outcome scores compared with those assigned to the control group. We are unable to explain the results of these findings. Moreover, the finding of this study is in agreement with the result of other randomized control trials of vitamin C, E, and β-carotene supplementations in high-risk patients with occlusive arterial disease or diabetes. In these cases vitamin C supplementation had no effect on the incidence of any type of vascular disease (fatal and nonfatal myocardial infarction and stroke), nor did it produce any significant reductions in the 5-year mortality. This result was found despite significant increases in the plasma concentrations of these vitamins ([@b8-cia-2-147]).

Confounding factors which may have been responsible for this lack of difference between the 2 groups associated with our study include: 1) Inappropriate timing of the vitamin C administration. Most of the oxidative stress damage is said to occur in the initial 24--48 hours post-stroke ([@b10-cia-2-147]), when one would expect a better response to antioxidants administration. Our patients were admitted 11 ± 6 days post-stroke. 2) Inappropriate dosing of vitamin C. It is possible that the dose of vitamin C was not high enough to exert its desired effect ([@b7-cia-2-147]). 3) Vitamin C may be a weak antioxidant in vivo, and its antioxidant effect may be more effective when given together with other antioxidant vitamins, as typically occurs in the diet ([@b19-cia-2-147]), rather than when taken by itself alone. 4) The pro-oxidant effect of vitamin C could be a mitigating factor. In vitro studies have shown that vitamin C has the ability to act as a pro-oxidant by chemically catalyzing hydroxyl-radical formation in the presence of metal, such as iron ([@b6-cia-2-147]; [@b1-cia-2-147]). Recent double-blind placebo controlled in vivo study of 22 patients undergoing vascular surgery for elective abdominal aortic aneurysm, and by-pass repair found vitamin C prophylaxis to promote oxidative lipid damage during surgical ischemia-reperfusion ([@b13-cia-2-147]). 5) Though our groups were (demographically and entry FIM) case-control, the vitamin C group was predominantly undernourished compared with the nonvitamin C group.

This study is limited by three considerations: i) the retrospective analysis of computerized stroke patient data, which inherently constrains the ability to randomize the patient population; ii) the small sample size, which limits the types of conclusions that can be tested statistically, eg, because of the potential for Type II statistical errors, and; iii) the subjects though matched for variables known to influence functional outcomes, they could not be matched for nutritional status or for pressure sores without changing the standard of care at our hospital. While this does place some constraints on the potential to draw conclusions from our data, it is possible that the observed trend toward worse outcomes for vitamin C-treated patients might be at least partially independent of the pre-entrance status of these individual. This is consistent with the recently published study showing a detrimental effect of vitamin C in surgical patients noted above ([@b13-cia-2-147]). Finally, our data suggest consideration, such as matching for nutritional status should be considered for future prospective, randomized trials.

Conclusion
==========

This study suggests that vitamin C supplementation in 1 gm dosage has no impact on motor recovery after ischemic stroke. Retrospective subgroup analysis of a small sub-population (n = 8) suggests a possible negative association between undernourished ischemic stroke patients, vitamin C treatment, or the combination of these factors in a rehabilitation population.

###### 

Baseline variables between the two patient groups based on the presence or absence of vitamin C intake (Mean ± SD)

  **Grouping variables**                                                              **Total population (n = 46)**   **Vitamin C (n = 23)**   **Control (n = 23)**   **P-value**
  ----------------------------------------------------------------------------------- ------------------------------- ------------------------ ---------------------- -------------
  Age in years[t](#tfn1-cia-2-147){ref-type="table-fn"}                               76 ± 11                         76 ± 11                  77 ± 11                0.84
  Sex (M:F)[c](#tfn2-cia-2-147){ref-type="table-fn"}                                  26:20                           13:10                    13:10                  1.0
  Onset to admission in days[t](#tfn1-cia-2-147){ref-type="table-fn"}                 11 ± 6                          12 ± 7                   11 ± 5                 0.38
  Stroke type:[c](#tfn2-cia-2-147){ref-type="table-fn"}                                                                                                               0.14
    Ischemic                                                                                                                                                          
      Thrombotic                                                                      33 (71%)                        19 (82%)                 14 (61%)               
      Embolic                                                                         10 (22%)                        02 (9%)                  08 (35%)               
      Carotid occlusion with stroke                                                   03 (7%)                         02 (9%)                  01 (4%)                
  Risk factors[c](#tfn2-cia-2-147){ref-type="table-fn"}                                                                                                               
    Hypertension                                                                      35 (76%)                        16 (70%)                 19 (83%)               0.29
    Diabetes mellitus                                                                 17 (37%)                        11 (48%)                 06 (26%)               0.12
    Hyperlipidemia                                                                    11 (24%)                        06 (26%)                 05 (22%)               0.72
    Myocardial infarction                                                             06 (13%)                        01 (4%)                  05 (22%)               0.06
    Congestive cardiac failure                                                        10 (22%)                        02 (9%)                  08 (35%)               0.47
    Atrial fibrillation                                                               09 (20%)                        02 (9%)                  07 (30%)               0.03
    Osteoarthritis                                                                    08 (17%)                        05 (22%)                 03 (13%)               0.43
  Prior level of independence                                                                                                                                         1.0
    Independent                                                                       36 (78%)                        18 (78%)                 18 (78%)               
    Independent with assistive device                                                 08 (17%)                        04 (17%)                 04 (17%)               
    Need physical assistance                                                          02 (4%)                         01 (4%)                  01 (4%)                
  Pressure sore[c](#tfn2-cia-2-147){ref-type="table-fn"}                              16 (35%)                        15 (65%)                 01 (4%)                0.0001
  Stroke severity:                                                                                                                                                    
    MMSE[m](#tfn3-cia-2-147){ref-type="table-fn"}                                     15 ± 11                         16 ± 10                  14 ± 12                0.70
    Visual field:[c](#tfn2-cia-2-147){ref-type="table-fn"}                                                                                                            0.12
    Normal                                                                            28 (61%)                        12 (52%)                 16 (70%)               
    Left homonymous hemianopsia                                                       04 (9%)                         04 (17%)                 00 (%)                 
    Right homonymous hemianopsia                                                      07 (15%)                        02 (9%)                  05 (22%)               
    Left visual neglect                                                               04 (9%)                         03 (13%)                 01 (4%)                
    Right visual neglect                                                              03 (6%)                         02 (9%)                  01 (4%)                
    UE MSS[t](#tfn1-cia-2-147){ref-type="table-fn"} (n = 16, n = 17) (range: 0--66)   29 ± 26                         25 ± 27                  33 ± 25                0.37
    LE MSS[t](#tfn1-cia-2-147){ref-type="table-fn"} (range: 0--34)                    14 ± 10                         14 ± 11                  14 ± 9                 0.95
    Limb placement[t](#tfn1-cia-2-147){ref-type="table-fn"}                           6 ± 4                           6 ± 4                    6 ± 3                  0.71
  TFIM Score---Admission[t](#tfn1-cia-2-147){ref-type="table-fn"}                     41 ± 18                         41 ± 18                  41 ± 18                0.99

**Note:** ^t^ Student's t-test;

Chi-square;

Mann--Whitney U test.

**Abbreviations:** LE, lower extremity; MMSE, Mini-Mental State Examination; MSS, Motor Status Score; SD, standard deviation; TFIM, total functional independence measure; UE, upper extremity.

###### 

Secondary outcome measures between the two patient groups based on presence or absence of vitamin C intake (Mean ± SD)

  **Grouping variables**                                                   **Vitamin C (n = 23)**   **Control (n = 23)**   **p-value**
  ------------------------------------------------------------------------ ------------------------ ---------------------- -------------
  Change in UDS TFIM Score[t](#tfn5-cia-2-147){ref-type="table-fn"}        20 ± 13                  26 ± 6                 0.20
  Change in UDS Cog-FIM Score[t](#tfn5-cia-2-147){ref-type="table-fn"}     3 ± 3                    4 ± 5                  0.41
  Change in UDS Motor-FIM Score[t](#tfn5-cia-2-147){ref-type="table-fn"}   15 ± 11                  20 ± 13                0.21
  Length of Stay (LOS in days)[t](#tfn5-cia-2-147){ref-type="table-fn"}    21 ± 9                   23 ± 9                 0.59
  Healed pressure sore[c](#tfn6-cia-2-147){ref-type="table-fn"}            05 (33%)                 00 (%)                 0.48
  Discharge disposition:[c](#tfn6-cia-2-147){ref-type="table-fn"}                                                          0.60
    Home                                                                   09 (39%)                 13 (57%)               
    Skilled nursing facility                                               10 (43%)                 09 (39%)               
    Acute hospital                                                         03 (13%)                 01 (4%)                

**Note:** ^t^ Student's t-test;

Chi-square.

**Abbreviations:** FIM, Functional Independence Measure; LOS, length of stay; UDS, unified data set.
